Hunan Warrant Pharmaceutical Co. Ltd. A (688799) — Capital Reinvestment Ratio
Hunan Warrant Pharmaceutical Co. Ltd. A (688799) has a Capital Reinvestment Ratio of 1.64x as of December 2024, meaning it reinvests 2% of its operating cash flow (CN¥142.23 Million) in capital expenditures (CN¥233.87 Million). Check 688799 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hunan Warrant Pharmaceutical Co. Ltd. A Capital Reinvestment Ratio (2019–2024)
This chart tracks Hunan Warrant Pharmaceutical Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see how efficiently does Hunan Warrant Pharmaceutical Co. Ltd. A generate cash.
Annual Capital Reinvestment Ratio for Hunan Warrant Pharmaceutical Co. Ltd. A (2019–2024)
Year-by-year Capital Reinvestment Ratio for Hunan Warrant Pharmaceutical Co. Ltd. A from 2019 to 2024. See Hunan Warrant Pharmaceutical Co. Ltd. A (688799) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.64x | CN¥142.23 Million | CN¥233.87 Million | ▲ +233.4% |
| 2023 | 0.49x | CN¥214.44 Million | CN¥105.76 Million | ▼ -41.8% |
| 2022 | 0.85x | CN¥155.65 Million | CN¥131.85 Million | ▲ +5.5% |
| 2021 | 0.80x | CN¥114.72 Million | CN¥92.10 Million | ▲ +56.3% |
| 2020 | 0.51x | CN¥104.66 Million | CN¥53.75 Million | ▲ +146.2% |
| 2019 | 0.21x | CN¥116.66 Million | CN¥24.34 Million | — |